Bionpharma Inc., founded on November 1, 2014, operates with a steadfast commitment to delivering value through quality. It is an emerging player in the U.S. generic pharmaceutical space, focusing on fostering patient-centric growth over mere profit. The company’s portfolio includes more than 20 Abbreviated New Drug Applications (ANDAs) and New Drug Applications (NDAs), reflecting its strategic mission of building 'Value driven by Quality.' Bionpharma underscores its dedication to excellence and innovation in product development, ensuring effective medicines are accessible for the U.S. healthcare system.
Guided by a team of seasoned professionals with over 100 years of collective expertise in the global generic business, Bionpharma is led by Venkat Krishnan as President and CEO. With more than two decades in the pharmaceutical industry, Venkat has a notable history of transforming North American operations at Ranbaxy, significantly growing sales to over $1 billion. The company further benefits from Gaurav Mehrotra's comprehensive financial stewardship as CFO and EVP of Commercial Operations, who successfully managed the growth trajectory for Ranbaxy in North America.
Lavesh Samtani leads the Business Development function as General Counsel, utilizing his extensive legal expertise in intellectual property and regulatory affairs. The commercial strategy is propelled by Bill’s leadership as EVP of Sales and Distribution; a seasoned professional recognized for launching key generic products to success in the market.
Nath coordinates supply chain operations and projects, leveraging over 25 years in the industry to streamline manufacturing processes globally. Complementing these efforts, Usha heads Regulatory Affairs with an impressive track record in navigating regulatory frameworks.
Iltifat oversees Quality Assurance functions, bringing over three decades of quality expertise from his roles at leading pharmaceutical companies. Bionpharma's operations are headquartered in Princeton, Florida, but maintain roots in New Jersey and Delaware. The company prides itself on a dynamic talent pool driving its global expansion and product distribution efforts.
For more information, visit their website [bionpharma.com](http://www.bionpharma.com).
KEY FACTS ABOUT BIONPHARMA INC.
-
US Businesses
-
Companies in Florida
-
Leon County Companies
- Company name
- BIONPHARMA INC.
- Status
- Active
- Filed Number
- F15000001645
- FEI Number
- 472021379
- Date of Incorporation
-
April 15, 2015
Age - 11 years
- Home State
- DE
- Company Type
- Foreign for Profit
CONTACTS
- Website
- http://bionpharma.com
- Phones
-
(609) 380-3310
(609) 380-3311
(888) 611-2466
(888) 235-2466
BIONPHARMA INC. NEAR ME
- Principal Address
- 400 Alexander Park,
Princeton,
NJ,
08540,
US
See Also